| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2017 | GENZYME CORPORATION |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination |
$210,000 | |
| 2017 | GENZYME CORPORATION |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$210,000 | |
| 2016 | GENZYME CORPORATION |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$260,000 | |
| 2016 | GENZYME CORPORATION |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$270,000 | |
| 2016 | GENZYME CORPORATION |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$280,000 | |
| 2016 | GENZYME CORPORATION |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$290,000 | |
| 2015 | GENZYME CORPORATION |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$260,000 | |
| 2015 | GENZYME CORPORATION |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$235,000 | |
| 2015 | GENZYME CORPORATION |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$260,000 | |
| 2015 | GENZYME CORPORATION |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$270,000 |
| Firm | Filings | Expenses |
|---|---|---|
| GENZYME CORPORATION | 40 | $20,095,155 |
| Issue | Activities |
|---|---|
| Pharmacy | 40 |
| Medicare/Medicaid | 40 |
| Taxation/Internal Revenue Code | 36 |
| Copyright/Patent/Trademark | 31 |
| Budget/Appropriations | 31 |
| Health Issues | 26 |
| Medical/Disease Research/Clinical Labs | 14 |
| Trade (domestic/foreign) | 10 |